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both patients had a long course of synovitis which re- 
quired antiinflammatory drugs to resolve. 
These two cases lend support to the hypothesis 
that calcium pyrophosphate dihydrate crystals pre- 
viously deposited in the cartilage are released during the 
acute infection by hydrolytic enzymes that digest carti- 
lage matrix, causing a crystal induced synovitis (2). A 
similar process may occur with uric acid crystals. Care- 
ful synovial fluid analysis late in the course of a septic 
arthritis by use of polarizing light microscopy may re- 
veal similar cases and thus support this hypothesis. 
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Further evidence for plasmapheresis 
To the Editor: 
In reference to the recent article by Wallace et a1 
on plasmapheresis and lymphoplasmapheresis (l), it 
is of interest to note that historical support for plas- 
mapheresis and other modalities to remove intra- 
vascular blood components has been largely anecdotal, 
though numerous case reports and testimonials cer- 
tainly exist in the literature. So impressive have been 
some of the observed results with one such therapy that 
Dr. James Johnson, FRS, was compelled to editorialize 
that it is “so highly useful.. .and one which, in many 
distressing diseases, contributes our chief and only rem- 
edy”(2). 
Westfall, in 1949, concluded that it may be use- 
ful “in all conditions where blood and lymph stasis ex- 
ists,’’ and that it clearly will “diminish inflammation, 
stasis, congestion of blood and lymph, and shorten the 
period of recovery from disease”(3). 
In fact, the first form of “controlled” plasmaphe- 
resis, lymphoplasmapheresis, indeed leuko-lympho- 
erythroplasmapheresis, was documented in the first cen- 
tury AD when Themison, founder of the Methodic Sect, 
wrote of its therapeutic application. Pliny first used it in 
the rheumatic diseases, finding dramatic responses in 
cases of gout (4), and Zacutus Lusitanus utilized this 
procedure successfully in acute arthritis of the hip (4). 
Numerous reports followed, verifying its effectiveness in 
a multitude of disorders of the liver, while Petrus Salius 
advocated its use in treating fever of many origins (4). 
But it was Heronymus Mercurialis, attendant 
physician to Pope Pius IV, who probably had the most 
keen perception of this modality. Though he used it ex- 
tensively, he observed that it was not altogether capable 
of removing the whole of the evil of which the patient 
might complain, “for the orifice made by the leech is so 
small,” he wrote, “that none but the thinner portions of 
the blood can escape; the thicker part, from which the 
evil arises, is still retained” (4). 
When a modality is developed which can aph- 
erese that “thicker part,” we will find a gratifying end to 
this business. 
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Hypermobility in psoriatic spondylitis 
To the Editor: 
Ankylosing spondylitis is characterized by fi- 
brous and bony ankylosis of the diarthrodial joints of 
the spine (1). This unique pathologic process results in 
limitation of spinal movement which can be assessed by 
a number of techniques (1,2). One commonly per- 
formed office method is the measurement of finger to 
floor distance with the patient in forward flexion (1). 
We report a patient with severe psoriatic spondy- 
